Genmab — Januar 2021
-
Teclistamab going to Japan - A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma https://www.clinicaltrials.gov/ct2/show/NCT04696809?cond=Multiple+Myeloma&sfpd_s=12%2F23%2F2020&sfpd_d=14&sel_rss=new14
-
the new Ph3 :
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer https://clinicaltrials.gov/ct2/show/NCT04697628 -
Det hjalp US kom på..:-)
-
Kortvarig...måske..:-D
-
Rutsjebanen...;-)
-
Genmab har en tilbøjelighed til at kunne give lidt sug i maven indimellem..:-D
-
Håbet er altid lysegrønt...:-)
-
Genmab to Present at the 39th Annual J.P. Morgan Healthcare Conference
https://ir.genmab.com/news-releases/
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
